News, archive: September 2018
Between January and August 2018, Russia produced 212.8 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms only 0.1% higher than that of the same period of 2017. In physical terms, Russia produced 2.61 bln units. The dynamics are -10.4%, which have been gradually decreasing for 10 months.
On the one hand, the first six months of 2018 for the Russian pharmaceutical retail was marked by a slight recovery in demand, which, despite failing to bring the segment out of the red zone, promised some growth by the end of the year, unless the macroeconomic situation changes.